Arkolith/Insider Trading/CTMX/Form 4

McCarthy Sean A.

CEO, DirectorCytomX Therapeutics, Inc. (CTMX) · full profile →Form 4 · filed Mar 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2025Sell(S)38K$0.60$23K995K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000086) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML